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Down syndrome (DS) individuals present increased risk for Alzheimer’s disease (AD)
neuropathology and AD-type dementia. Here, we investigated the use of green tea
extracts containing (-)-epigallocatechin-3-gallate (EGCG), as co-adjuvant to enhance the
effects of environmental enrichment (EE) in Ts65Dn mice, a segmental trisomy model of
DS that partially mimics DS/AD pathology, at the age of initiation of cognitive decline.
Classical repeated measures ANOVA showed that combined EE-EGCG treatment was
more efficient than EE or EGCG alone to improve specific spatial learning related
variables. Using principal component analysis (PCA) we found that several spatial learning
parameters contributed similarly to a first PC and explained a large proportion of the
variance among groups, thus representing a composite learning measure. This PC1
revealed that EGCG or EE alone had no significant effect. However, combined EE-EGCG
significantly ameliorated learning alterations of middle age Ts65Dn mice. Interestingly,
PCA revealed an increased variability along learning sessions with good and poor learners
in Ts65Dn, and this stratification did not disappear upon treatments. Our results suggest
that combining EE and EGCG represents a viable therapeutic approach for amelioration
of age-related cognitive decline in DS, although its efficacy may vary across individuals.
Keywords: Down syndrome, aging, (-)-epigallocatechin-3-gallate, Morris water maze, principal component
analysis
INTRODUCTION
Down syndrome (DS) is the most prevalent genetic cause of intellectual disability arising from
trisomy of chromosome 21 with an incidence of approximately 1 in 1000 live births worldwide.
DS affects the development and function of the central nervous system throughout life, leading
to a distinctive profile of cognitive impairment and increased risk for Alzheimer’s disease (AD)
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neuropathology. By the age of 40, almost all DS adults develop
AD-like neuropathology and by the age of 55–60, around 70%
develop dementia (Wilcock and Griffin, 2013). DS brains exhibit
extracellular deposition of amyloid-ß (Aβ), following a fronto-
striatal pattern (Wisniewski et al., 1985; Mann, 1988; Lemere
et al., 1996), while hyperphosphorylated tau, in the form of
neurofibrillary tangles, accumulates later in life affecting mainly
the hippocampal formation, the entorhinal cortex, and the
neocortex (Hof, 1995; Hyman, 1995).
So far, therapeutic interventions aimed at slowing down
cognitive decline in AD such as N-methyl-D-aspartate (NMDA)
receptor antagonists (memantine), anticholinesterase inhibitors
(donepezil, rivastigmine, galantamine), or GABA-A antagonists
have not been able to demonstrate improvements in cognitive
performance in demented nor in young non-demented DS
subjects (De la Torre and Dierssen, 2012). In recent years,
treatment with (-)-epigallocatechin-3-gallate (EGCG), the most
abundant polyphenol found in green tea, has gained attention as
it has beneficial effects in ADmouse models possibly contributed
by its antioxidant activity, free radical scavenging, iron chelating,
anti-inflammatory effects, neuroprotection, and promotion of
the non-amyloidogenic pathway of APP through ADAM10
maturation (Obregon et al., 2006; Kalfon et al., 2007; Rezai-Zadeh
et al., 2008; Biasibetti et al., 2013; Kim et al., 2014). Interestingly,
EGCG also has inhibitory properties on the kinase activity of
DYRK1A (Bain et al., 2003; Adayev et al., 2006; Wang et al.,
2012), a DS candidate whose overabundance is associated with
DS neurocognitive symptoms and neurodegenerative phenotypes
(Becker et al., 2014). EGCG ameliorates cognitive deficits not
only in AD and DS mouse models, but also in young adults with
DS (Lee et al., 2013; De la Torre et al., 2014).
Additionally, non-pharmacological therapeutic intervention,
such as environmental enrichment (EE), has been successfully
used in mouse models of AD (Jankowsky et al., 2005; Lazarov
et al., 2005; Berardi et al., 2007; Li et al., 2013; Polito et al., 2014)
and DS (Martínez-Cué et al., 2002, 2005; De la Torre et al., 2014).
Interestingly, many of the effects reported for EE are similar to
those observed upon EGCG treatment, such as neuroplasticity
enhancement, antioxidant activity, anti-inflammatory function,
neuroprotection, and promotion of the non-amyloidogenic
proteolytic pathway of APP (Ickes et al., 2000; Jankowsky et al.,
2005; Birch et al., 2013; Mármol et al., 2015). In fact, EE has
also been shown to normalize the expression levels and the
kinase activity of DYRK1A in mice overexpressing Dyrk1A and
in Ts65Dn mice (Golabek et al., 2011; Pons-Espinal et al., 2013).
In the present study, we investigated the effects of combined
treatment with EGCG and EE on hippocampal-dependent
learning and memory, which is one of the cognitive domains
most susceptible to age-associated decline and primarily affected
in AD and DS (Granholm et al., 2000). To this end, we used
the Ts65Dn mouse model of DS, which bears a segmental
trisomy for MMU16 (syntenic region to HSA21) from Mrpl39
to Zfp295 covering APP and DYRK1A, and shows predictive
validity with DS (reviewed in Dierssen, 2012) including AD-like
cholinergic neuronal loss and age-associated cognitive decline
(Holtzman et al., 1996; Seo and Isacson, 2005; Contestabile et al.,
2006). The Ts65Dn mouse model only partially recapitulates
AD pathology since it does not exhibit extracellular β-amyloid-
containing plaques or neurofibrillary tangles. However, it
develops other abnormal neuronal processes associated to Aβ
production such as enlarged neuronal early endosomes, or
increased immunoreactivity for markers of endosome fusion
and recycling (Cataldo et al., 2003) that lead to alterations in
NGF retrograde transport from the hippocampus to the BF
(Salehi et al., 2006). Thus, it is an adequate model to investigate
potential therapeutic interventions to tackle some of the common
pathogenic mechanisms between DS and AD.
We assessed the effects of the treatments on spatial learning
and memory performance in the Morris water maze by using
classical single-variate measures such as escape latency, Gallagher
index or thigmotaxis. However, learning is a process that involves
the orchestration of a myriad of cognitive and behavioral
outcomes, and a single variable cannot capture its essence.
Learning is also measured by variables that are themselves
influenced by different factors. Only under certain conditions
will these measures provide the information they were designed
for (e.g., latency is a good measure if all animals have the same
speed, or the time spent in the periphery if it is associated with
thigmotactic behavior). Such idealizations are hard to justify in
an experimental context where high variability between subjects
is the rule, not the exception. PCA allowed to assess the learning
impairment in Ts65Dn mice and the effects of EE, EGCG,
and EE-EGCG treatments in a less variable-dependent manner.
We examined the relative contribution of seven behavioral
variables to the variance in the data obtained frommultiple water
maze measurements. We identified two composite variables that
together explained 86% of the variance among groups: one
related to learning, and the other one mainly measuring the
component of swimming speed that is not target-directed.
MATERIALS AND METHODS
Ts65Dn Mouse Colony
Ts65Dn and wild type (WT) littermate mice were obtained
through repeated crossings of B6EiC3Sn a/A-Ts(1716)65Dn
(Ts65Dn) females to B6C3F1/J males purchased from The
Jackson Laboratory (Bar Harbor, ME). The mouse colony was
bred in the Animal Facilities of the Barcelona Biomedical
Research Park (PRBB, Barcelona, Spain, EU). Mice were housed
in standard or enriched conditions (see below) under a 12:12 h
light–dark schedule (lights on at 8:00 a.m.) in controlled
environmental conditions of humidity (60%) and temperature
(22 ± 2◦C) with food and water ad libitum. Both the Ts65Dn
and euploid mice were genotyped by qPCR, in accordance with
the Jackson laboratories protocol (https://www.jax.org/research-
and-faculty/tools/cytogenetic-and-down-syndrome-models-
resource/protocols/cytogenic-qpcr-protocol).
Experiments were conducted using 5–6 months old female
mice. This age represents the starting point of gradual cognitive
decline (Granholm et al., 2000) and we used females since
Ts65Dn males show high levels of stress in EE conditions that
could mask the effect of the treatments (Martínez-Cué et al.,
2002). All animal procedures met the guidelines of European
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Community Directive 2010/63/EU and the local guidelines
(Real Decreto 53/2013) and were approved by the Local Ethics
Committee (Comité Ético de Experimentación Animal del PRBB
(CEEA-PRBB); procedure numbers MDS-08-1060P2 and MDS-
14-1611).
Treatment: Environmental Enrichment
Housing Conditions and
(-)-epigallocatechin-3-gallate (EGCG)
Ts65Dn and WT 5–6 months old female mice were randomly
assigned to one of the following experimental groups: no
treatment (NT), environmental enrichment (EE), green tea
extract containing 45% (-)-epigallocatechin-3-gallate (EGCG),
or a combination of EE and EGCG (EE-EGCG). Mice received
the different treatments for 30 days based on previous studies
(Pons-Espinal et al., 2013; De la Torre et al., 2014). In the
NT condition animals were reared in conventional cages (20 ×
12× 12 cm height, Plexiglas cage) in groups of 2–3 animals.
EE housing consisted of spacious (55 × 80× 50 cm height)
Plexiglas cages with toys, small houses, tunnels, and platforms
of different shapes, sizes, colors and textures. Wheels were not
introduced in the cages in order to avoid the effect of physical
exercise. The arrangement was changed every 2 days to keep
novelty conditions. To stimulate social interactions, 6–8 mice
were housed in each cage. EGCG was administered in drinking
water (EGCG dosage: 0.326mg/ml, 0.9mg per day; 30mg/Kg
per day) by preparing fresh EGCG solution every 2 days from
a green tea leaf extract [Mega Green Tea Extract, Decaffeinated,
Life Extension R©, USA; EGCG content of 326.25mg per capsule].
Even if there were fluctuations in EGCG dosage due to drinking
volume and mice weight there were no significant differences in
mean EGCG intake along days between WT (29.79mg/Kg per
day) and Ts65Dn (32.59mg/Kg per day) mice (data not shown).
The sample size for each experimental group was the following:
WT= 10; TS= 11; WT-EE= 14; TS-EE= 11; WT-EGCG= 11;
TS-EGCG= 9; WT-EE-EGCG= 12; TS-EE-EGCG= 8.
Morris Water Maze
The water maze consisted of a circular pool (1.70m diameter;
0.6m height) filled with tepid water (19 ± 2◦C) opacified by the
addition of white non-toxic paint. White curtains with affixed
black patterns surrounded the maze to provide an arrangement
of spatial cues. The settings enabled a spatial allocentric learning
and memory task based on distal cues (Vorhees and Williams,
2006). The first day mice were habituated to the task at the pre-
training session in which the escape platform (12 cm diameter,
height 24 cm) was located at the center of the pool and was
visible by 1 cm over the water level. During the following 5 days
mice learned the position of the platform, which was hidden
1 cm below water (northeast quadrant, 22 cm away from the
wall) in 4 training (acquisition) trials per day. In each trial, mice
were placed at one of the starting locations in random order
(north, south, east, west), including permutations of the four
starting points per session, and were allowed to swim until they
located the platform. Mice failing to find the platform within
60 s were placed on it for 20 s and were returned to their home
cage at the end of every trial. To assess the reference memory
a probe session was performed 24 h after the last acquisition
session. The platform was removed and mice were allowed to
swim for 60 s during which the % of time spent in the target
quadrant and the proximity to platform (Gallagher index) was
calculated by sampling the position of the animal in the maze
(10 times per second) to provide a record of its distance to
the escape platform in 1-s averages (Gallagher et al., 1993).
The cued session was performed to test the mice motivation to
find the platform and visual ability using the platform elevated
1 cm above the water with its position clearly indicated by a
visible cue (black flag). Mice that did not reach the platform in
less than 30 s in this session were considered unsuitable for the
test and were subtracted from the analysis. During days 8–10,
cognitive flexibility, the ability of mice to re-learn a new location
of the platform, was assessed in the reversal sessions in which
the platform was located at the opposite quadrant. There was 1
missing subject on the reversal sessions.
All the trials were recorded with an image tracking system
(SMART, Panlab, Spain) connected to a video camera placed
above the pool. Escape latencies, length of the swimming
trajectories and swimming speed for each animal and trial were
monitored and computed. The analysis of mice performance was
conducted using a custom-designed analysis program, Jtracks
software, which generates heat-maps of the spatial distribution
of the accumulated trajectories in each group. Jtracks was further
used to obtain other measurements such as the Gallagher index
and the Whishaw index, defined as the percentage of path inside
the optimal corridor connecting release site and goal, to quantify
the most efficient and direct trajectory from the location of mice
to the platform (Whishaw and Jarrard, 1996).
Statistical Analysis
Two questions were addressed: the global differences over time
and the progression of learning across sessions. The first question
was tested by single variate analysis of the differences between
experimental groups for three learning-related parameters
(latency to reach the platform, Gallagher index and % of time
spent in the periphery). Data were expressed as mean + S.E.M
and analyzed using One-way ANOVA or ANOVA repeated
measures. The second question was evaluated by estimating the
linear effect of time-group interaction using a general linear-
mixed model for each behavioral parameter. We associated
random-effects terms with the animal factor in order to model
within-subject correlation that appears due to the repeated nature
of the data. Also, the variable “latency” was right-censored, since
mice are allowed to swim a maximum of 60 s (Vock et al.,
2012). Estimation of the coefficients and their associated p-values
were based on maximum log-likelihood methods using the R
library censReg (Henningsen, 2013). We used the plot of the
model residuals vs. the fitted values to check model assumptions.
Multiple comparisons for parametric model were used to address
post-hoc comparisons using multest R package and glht function
(Hand and Taylor, 1987; Dickhaus, 2012). Non-treated WT
and Ts65Dn were considered as the reference groups for the
comparisons. To control the false discovery rate (FDR) due
to multiple post-hoc comparisons Benjamini-Hochberg method
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was used (Benjamini and Hochberg, 1995). This procedure was
implemented both for the ANOVA and for the linear-mixed
model in the R package multtest (Pollard et al., 2005).
Principal Component Analysis
The “learning” process is composed by many variables whose
influence on performance may be great for some, whereas for
others it may be so small that they can be ignored. For example,
you might start with ten original variables, but might end with
only two or three meaningful axes. This is known as reducing
the dimensionality of a data set. PCA is the most commonly
used technique to identify linear combinations of variables in
a high-dimensional space best representing the variance that is
present in the data. This is achieved by considering each variable
to be an axis in a high-dimensional space. Individuals, or groups
of individuals, can be represented as points in this space. PCA
identifies a linear combination of the original variables, called
principal component that accounts for the largest amount of the
experimental variability. Once this first principal component is
set, PCA finds successive orthogonal principal components that
explain the maximum amount of the remaining variance given
that the orthogonality constraint is met. Finally, the original
data and the original variables can be projected in this new
space defined by the principal components. In our analysis we
were mainly interested in the variation among experimental
groups as well as the variation of a given group along the
learning sessions. To find the variables best representing these
two types of between-group variation (within- and between-
learning sessions), we used the group medians of each variable
on each acquisition day. A supervised analysis using group
means instead of variables measured on individuals is known
as discriminant analysis, (c.f. Greenacre, 2010). Such methods
are suitable for the analysis of behavioral data having several
conditions with a number of replicates per condition. For reasons
of robustness to outliers, however, we here prefer to use the
medians instead of the means. The PCA was performed on
40 observations (eight experimental groups on five learning
sessions, where the four trials of each learning session were
averaged) corresponding to median group performances of seven
variables on each acquisition day. Separately, a similar analysis
was done for the three reversal sessions.
The variables of interest were latency to target, percentage of
time spent in target quadrant, percentage of time spent in the
periphery, Whishaw index, Gallagher index, distance traveled,
and speed. To allow for the combination of the original variables
measured in different units, all variables were scaled to unit
variance before the analysis (the default Z-score scaling was
used).
Since the PCA was performed on group medians (grouped
data), points identified in the PCA space will correspond to
groups of individuals. To identify points corresponding to
individuals themselves, we used the technique of “adding
supplementary points.” Given a single measurement
corresponding to a point in the space of the original variables,
we can identify the new coordinates of this point in the space
defined by the principal components. Note that such points will
not change the coordinate system, as they are added after the
PCA is performed. Adding all 86 individuals appearing five times
each as supplementary points, we identified the coordinates for
each of the individuals. The R-package FactoMineR (Lê et al.,
2008) was used for the PCA as it allowed for a straightforward
inclusion of supplementary observations. Density plots were
obtained using the statdensity_2d function from the ggplot2 R
package (Wickham, 2009) with the parameters: n = 100, h = 5,
and bins= 6.
Permutation Test
To assess statistical significance of group separation, we
performed a permutation test, a standard procedure in
multivariate data analysis (Sham and Purcell, 2014). Individuals
were drawn and reassigned randomly to experimental groups.
Correct acquisition sessions were maintained, and thus each
individual kept their learning performance along acquisition
(i.e., all five values corresponding to the learning sessions of an
individual were assigned to the same group). Group medians
were then determined for each learning session for these new
groups. Original numbers of individuals in each group were kept.
To determine overall group separation, percentage of within-
session variance (see variance decomposition below) was used as
a statistic. For learning differences, we used a t-statistic involving
PC1 pairwise group comparisons. All pairwise comparisons were
determined at each permutation. The number of randomized
PCAs was 10,000.
Variance Decomposition
Total, between-group, between-session, and within-session
variances were directly calculated from the (standard)
coordinates obtained from the PCA. Variance in the PCA
was calculated from the distances d of objects i from the origin:
V =
1
7N
N∑
i= 1
d
2
i
where the factor 1/7 comes from the number of variables. In
the case of between-group variance VB, the objects i are the
groups and N = 40. Since we performed the PCA on the groups,
by construction the between group variance sums to 1. For the
total variance VT , the objects are the individuals (supplementary
points) and N = 430. The percentage of between-group variance
is then VB/VT x 100. The usual definition of VB is for the
group averages, not medians, which means that here we are
actually estimating a lower bound on the percentage of between-
group variance. To obtain the between-sessions variance VBS, we
calculated the squared mean distance from the origin over all
groups on a given acquisition session s:
d
2
s
=
7∑
p= 1

1
8
8∑
j= 1
xs,p,j


2
where the xs,p,j are the standard coordinates for principal axis
p of an experimental group j during a given session s. Then we
used the first formula for the variance withN = 5.Within-session
variance is the difference VB – VBS (which can again be expressed
as a percentage of total variance VT).
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RESULTS
To evaluate the functional impact of EE, EGCG, and the potential
synergistic effects of a combination of EE-EGCG on the age-
associated hippocampal-dependent learning andmemory deficits
of Ts65Dn mice, we compared the behavioral performance of
mice treated with EE, EGCG, or EE-EGCG in the MWM with
their untreated controls of both WT and Ts65Dn genotypes.
Two different questions were addressed: the overall learning
differences among the experimental groups on single learning
variables (escape latency, Gallagher index etc.) and the effects
of treatments on the progression of learning across sessions
(slope of the learning curve). The first question was evaluated by
analyzing the effect of the group variable (defined by genotype
and treatment) by one-way repeated measures ANOVA. The
second question was evaluated by estimating the linear effect
of time-group interaction with a general linear-mixed model on
each behavioral parameter, censored for latency.
Effects of EE, EGCG, and EE-EGCG
Treatments
First we performed a classical single-variate analysis including
relevant parameters for the learning process. During the
habituation (pre-training) session, all groups behaved in a similar
manner, with no differences in the latency to reach the visible
platform [overall genotype-treatment effect F(7, 78) = 0.937; p-
value n.s.] or the mean distance to the platform, as quantified by
the Gallagher index [overall genotype-treatment effect F(7,78) =
1.161; p-value n.s.] indicating no genotype- or treatment-
dependent differences in procedural learning (Figure 1A).
Along the acquisition sessions, untreated WT mice efficiently
learned the platform position, as shown by the progressive
reduction in the latency to reach the hidden platform and the
increasing preference for the target quadrant (Figures 1A–C). As
it has been previously reported, we detected impaired learning
ability in untreated Ts65Dn mice, shown by the higher latency
to reach the hidden platform across days that was not reduced
FIGURE 1 | EE-EGCG treatment is more efficient than EE or EGCG alone to ameliorate the hippocampal-dependent learning and memory alterations
of middle age Ts65Dn mice. (A) Heat-map representing the accumulated trajectories of mice from the different experimental groups [untreated wild type (WT) = 10,
untreated Ts65Dn (TS) = 11 WT-EE = 14; TS-EE = 11; WT-EGCG = 11; TS-EGCG = 9; WT EE-EGCG = 12; TS EE-EGCG = 8] across sessions in the Morris water
maze. Color scale is depicted on the right, where red corresponds to the most visited zones and black to the less or non-visited zones. (B) Latency (seconds to reach
the escape platform). (C) Gallagher index (mean distance between subject and goal in cm). (D) Thigmotaxis (percentage of time spent on the periphery). Data in (B–D)
are represented as mean ± SEM. Data were analyzed with ANOVA repeated measures with Tukey post-hoc comparisons corrected with BH; *p < 0.05, **p < 0.01.
PRE, pre-training; A1-5, acquisition days 1–5 with 4 trials per day; REM, removal. All the possible post-hoc comparisons were performed but only treated TS, and
untreated WT and TS groups are shown in the figure.
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across sessions, leading to a flatter learning curve (β = −3.05;
p-value < 0.01, Figure 2A) in comparison to untreated WT.
Trisomic mice also showed increased global Gallagher index
[overall genotype-treatment effect F(7, 78) = 7.072, p-value <
0.01; Tukey post-hoc BH corrected p-value < 0.01, Figure 1C]
and the typical increased thigmotaxis [higher percentage of time
spent close to the pool periphery; overall genotype-treatment
effect F(7, 78) = 6.12, p-value < 0.01; Tukey post-hoc BH
corrected p-value < 0.05, Figure 1D] that has been previously
reported (Reeves et al., 1995).
EE ameliorated the deficits found in Ts65Dn mice as shown
by a reduction of the escape latency across acquisition sessions
as compared to untreated trisomic mice (β = −2.92; p-value <
0.05, Figure 2A). Interestingly, enriched Ts65Dn (TS-EE) mice
also exhibited a more goal-directed behavior as shown by a
progressive reduction of the Gallagher index (β = −2.23; p-value
< 0.05, Figure 2B) and of thigmotactic behavior (β = −3.47;
p-value < 0.05, Figures 1A, 2C) in comparison to untreated
trisomic mice. However, Ts65Dn mice under EE still showed
poorer performance when compared toWT as reflected by higher
Gallagher index values (Tukey post-hoc BH corrected p-value <
0.01, Figure 1C) and thigmotaxis (Tukey post-hoc BH corrected
p-value < 0.05, Figure 1D).
Conversely, Ts65Dn mice treated with EGCG (TS-EGCG)
did not show any effects of treatment. In this group, neither
the latency to reach the platform (β = −1.99; p-value = n.s.,
Figure 2A) nor the Gallagher index (β = −2.09; p-value = n.s.,
Figure 2B), were improved as compared to untreated Ts65Dn
mice. In fact, TS-EGCG mice exhibited increased thigmotactic
behavior (β = −5.39; p-value < 0.01, Figure 2C).
Finally, the combined treatment with EE-EGCG significantly
improved performance in Ts65Dn mice, markedly reducing
the latency to reach the platform (β = −4.83; p-
value < 0.01, Figure 2A), Gallagher index (β = −4.04;
p-value < 0.01, Figure 2B) and thigmotaxis (β = −5.18;
p-value < 0.01, Figure 2C) across the acquisition sessions as
compared to untreated trisomic mice. In fact, the combined
treatment effects in Ts65Dn mice reached values that were
not statistically different from those of untreated WT
mice in latency (β = −1.78; p-value = n.s., Figure 2A),
Gallagher index (Tukey post-hoc BH corrected p-value
= n.s., Figure 1C) and thigmotaxis (Tukey post-hoc BH
corrected p-value n.s., Figure 1D) suggesting a rescue of the
phenotype.
Neither of the treatments had effects on the latency to reach
the platform, nor on the Gallagher index in WT mice. However,
both EE (β = −3.11; p-value < 0.05, Figure S1) and EE-
EGCG (β = −3.94; p-value < 0.01, Figure S1) promoted a
significant reduction in the percentage of time in the periphery
along acquisition days.
There were no differences in swimming speed between
untreated WT and Ts65Dn mice (overall gen-treatment effect
F(7, 8) = 2.820; p-value < 0.05; Tukey post-hoc comparisons
corrected by BH showed p-value = n.s.; data not shown). On
the other hand EGCG treatment had a significant effect reducing
swimming speed onWT (Tukey post-hoc BH corrected p-value<
0.05; data not shown) and Ts65Dn (Tukey post-hoc BH corrected
p-value < 0.01; data not shown) in comparison with untreated
WT. The rest of the treatments showed no effect on swimming
speed during learning.
Effects of EE, EGCG, and EE-EGCG
Treatments on Reference Memory and
Cognitive Flexibility
To assess the reference memory a probe trial was performed
24 h after the last acquisition day. The percentage of time
spent in the target quadrant showed a tendency in untreated
Ts65Dn to perform worse than WT and also in EE-EGCG
treated Ts65Dn mice to perform better than untreated Ts65Dn,
however there were no statistically significant differences among
the groups [overall genotype-treatment effect F(7, 78) = 1.498;
p-value = n.s.; Figure S2]. This was probably due to the large
within-group variance as depicted in the boxplots, by the large
FIGURE 2 | Linear mixed model reveals improvement of hippocampal-dependent learning upon EE and EE-EGCG treatment in middle age Ts65Dn
mice. Fitted linear mixed model (represented as colored lines) and observations (dots) represented as mean ± SEM of (A) Latency to reach the escape platform
(log-transformed censored model), (B) Gallagher index, and (C) thigmotaxis along learning sessions. The model enabled the comparison of the slope of the learning
trajectory (β) across days among experimental groups. Post-hoc comparisons were corrected with BH; *p < 0.05, **p < 0.01; non-treated WT and TS were
considered as references for the comparisons.
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distance between the box edges (25th and 75th percentiles;
Figure S2). On the other hand, the Gallagher index, which is a
more precise measure, presented less within-group variance and
showed global differences in performance among experimental
groups [overall genotype-treatment effect F(7, 78) = 2.741; p-
value < 0.05, Figure 3]. Tukey post-hoc comparisons adjusted
by the BH method showed that untreated Ts65Dn presented
higher Gallagher index than untreated WT mice (p-value <
0.05) indicating poor reference memory. The administration of
EGCG (Tukey post-hoc BH corrected p-value= n.s) or EE (Tukey
post-hoc BH corrected p-value = n.s) alone did not affect the
Ts65Dn reference memory deficit. However, the combination of
EE-EGCG reduced the Gallagher index in Ts65Dn (Tukey post-
hoc BH corrected, p-value = 0.05), reaching a performance that
was similar to WT (Tukey post-hoc BH corrected p-value = n.s.,
Figure 3).
Cognitive flexibility was assessed along the reversal sessions.
While untreated WT mice clearly shifted their search to the new
platform location, untreated Ts65Dn mice persevered searching
the old platform location. This poorer cognitive flexibility was
reflected in an increased latency to reach the new platform
position [overall genotype-treatment effect F(7, 77) = 5.648,
p-value < 0.01; Tukey post-hoc BH corrected p-value < 0.01,
Figure S3A], a trend toward an increased Gallagher index
[overall genotype-treatment effect F(7, 77) = 7.438; Tukey post-
hoc BH corrected p-value = 0.06, Figure S3B] and increased
thigmotaxis across the 3 reversal learning sessions [overall
genotype-treatment effect F(7, 77) = 4.570; Tukey post-hoc BH
corrected p-value < 0.05; Figure S3C], as compared to WT. Even
though there were no significant effects of any of the treatments
on Ts65Dn latency to reach the new platform positions, both TS-
EE (β = 11.78, p-value < 0.05, Figure S3A) and TS-EE-EGCG
(β = 11.95, p-value < 0.05, Figure S3A) were qualitatively less
different from WT than untreated Ts65Dn mice (β = 18.46, p-
value < 0.01, Figure S3A) taking into account the magnitude
of the group differences by the model estimate (β). Neither of
the treatments had effects on the Gallagher index (Figure S3B)
nor the thigmotaxis on Ts65Dn or WT mice during the reversal
sessions (Figure S3C).
Multidimensional Analysis of Learning
Impairment in Ts65Dn Mice: Global Effects
of EE, EGCG, and EE-EGCG Treatments
There is not a single best measure of learning (such as the classical
“escape latency” or “distance traveled”) and thus, discrimination
of learning performance differences could be better achieved by a
combination of some of these variables. Thus, to go a step further,
we used permutation-validated principal component analysis
(PCA), to determine which combination of the experimental
variables would be best suited to describe the differences in
learning among our groups. Significance of differences was
determined by permutation-based test statistics.
Variables related to the learning improvement along the five
learning sessions, including Gallagher index, % time spent in
target quadrant, distance traveled, percentage of time spent
in periphery, Whishaw index and latency to target, loaded
on PC1, which accounted for 74% of the (between-group)
variance (Figures 4A,C). High values of PC1 correspond to short
distances to target, low latencies, high percentages of time in the
target quadrant, etc. (Figure 4B). This axis can be understood
as a new composite learning measure. In contrast, the second
principal axis (PC2, 12% of variance) is dominated by the
contribution of swimming speed and thus is mainly dependent
on motor ability. By construction, it is independent from the
learning-related PC1. It is noteworthy that speed also contributes
FIGURE 3 | EE-EGCG treatment is more efficient than EE or EGCG alone to ameliorate reference memory at the probe trial in Ts65Dn group. The figure
shows boxplots of the distribution of the distance to the target (Gallagher index) of all experimental groups in the removal session. In each boxplot, the horizontal line
corresponds to group median, the box edges gives the 25th and 75th percentiles and the whiskers depict minimum and maximum values to a maximum of 1.5 times
the interquartile distance from the box, and more extreme values are individually plotted. Red dots indicate the values of each individual mouse. TS-EE-EGCG showed
a reduction of Gallagher index when compared to untreated TS mice that is not observed in the rest of TS mice groups. ANOVA, with Tukey post-hoc comparisons
corrected with BH; *p < 0.05; #p = 0.05; comparisons were performed to test the differences between genotypes and the effects of treatments on the TS.
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FIGURE 4 | Supervised PCA of the experimental groups during the acquisition sessions revealed the main direction of learning along the first principal
component. (A) Distribution of the group performance (medians) in the new ordination space, which consists of linear combinations of the original variable space.
Each trajectory represents an experimental group and connects the five learning sessions labeled with its respective number. All group trajectories showed a
progression toward positive values of the first principal component (PC1). For a given learning session, experimental groups achieving better performance attain higher
values on this axis. The progression of trajectories on the second principal component (PC2) appears more erratic. (B) PCA of the variables, where arrows represent
the direction of each variable in the PCA space. Arrows reaching the unit circle belong to variables that are well represented by the two principal components. (C) Bar
plots showing the percentage of explained variance for each principal component. Bars represent the contribution (%) of each variable to first and second principal
components. The first principal component (left panel) can be interpreted as a composite learning variable where classical variables used to assess learning had major
and similar contribution ranging from 18% in the case of the Gallagher index to 10% in the case of the latency. Speed (right panel) constitutes the main contributor to
PC2 (82%), but is split between PC1 and PC2 in almost equal parts (see panel B).
to PC1, where it shows a relation to learning (animals that have
learned the target position tend to go there faster). Speed is thus
decomposed in a learning-dependent component and a learning-
independent component more related with the intrinsic motor
capability of mice (Figure 4B).
Each of the eight experimental groups is represented as
a trajectory connecting five dots that correspond to the five
learning sessions (see Figure 4A). Each group trajectory shows
a main direction from left to right (along PC1) that represents
the group’s overall learning and off-target speed (speed in swim
paths not goal-directed). For instance, the untreated Ts65Dn
group trajectory reaches a maximum value of PC1 at the
end of the learning phase (last learning session corresponding
to their best performance level) that corresponds to initial
PC1 values (learning sessions 1 and 2) of the untreated WT
trajectory, indicating poor learning associated with the trisomy.
Interestingly, the Ts65Dn group treated with EE-EGCG shows a
trajectory that advances well into the right quadrants, attaining
maximum values of PC1 that equal those reached by untreated
WT at the end of the learning phase (efficient learning trajectory).
There are also interesting differences in the second dimension
(PC2). The most striking is that untreated WT follow an
opposite trajectory to the EGCG-treated WT. Both groups reach
the lowest and highest values of PC2, respectively, indicating
opposite changes in swimming speed during learning upon
treatment. Generally, trajectories of EGCG-treated groups have
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higher values of PC2 than their untreated counterparts (with
significant differences in PC2 between the EGCG treated WT
and the untreated WT group, as well as between the EGCG
treated Ts65Dn and the untreated Ts65Dn group on session
5, by permutation test). This indicates a general reduction in
swimming speed due to EGCG treatment (data not shown).
To assess the statistical significance of these differences, we
determined the amount of individual variation within each
group by mapping the position of each individual on each
acquisition day to the PCA plot (see Materials and Methods). As
shown in Supplementary Figure 4, there is a substantial amount
of individual variation across the learning sessions in all the
experimental groups. In fact, the within-group variance attains
60% of the total variance (the between-group variance amounts
to about 40% of the total, see Materials and Methods). Part
of the between-group variance stems from the variance among
learning sessions, so that the amount of between-group variance
can further be decomposed into between-learning sessions
(17%) and within learning-session (23%). While the former
quantifies how an average group performance varies across
learning sessions, the latter quantifies the average separation of
the experimental groups. This separation is highly significant
(p < 10−4, permutation test, see Materials and Methods).
Figure 5 density plots show the individual variation within the
Ts65Dn experimental groups during the learning process. While
individuals started off from similar positions on learning session
1 (Figure 5A), on session 5 (Figure 5B) the trisomic groups
spread out indicating increasing variation along the learning
process. This would represent the phenotypic variability that is
specifically due to learning, whereas the variation in baseline
(contributed by other motivational or motor factors) is much
smaller. Statistical significance of differences in learning was
evaluated via a permutation test involving a t-statistic based
on PC1. This analysis showed significant differences between
the EE-EGCG treated and untreated Ts65Dn (p-value < 0.01)
and EE-EGCG treated and EGCG treated Ts65Dn (p-value <
0.05) at the end of the learning period (session 5, Figure 5D),
which were not observable during the first learning session
(Figure 5C). WT mice manifested a more homogenous behavior
with all groups starting from similar values in session 1 (Figure
S5A) and reaching similar learning performance in session 5
(Figure S5B). WT mice showed no significant difference among
treatments neither in the first session (Figure S5C) nor at the end
of the learning process (Figure S5D). Significant pairwise group
comparisons during learning sessions 1 and 5 based on PC1 can
be found in Supplementary Tables 1, 2, respectively.
We used the same approach to analyze the data from
the reversal sessions. In this case, PC1 can be interpreted as
a learning composite variable explaining cognitive flexibility
(Figure S6). We observed that both Ts65Dn (Figures S7A, S7B)
and WT (data not shown) mice achieved higher values on
PC1 along the sessions. However, there were no significant
effects of the treatments within the same genotype on the last
reversal session (Figure S7D), although there is a trend toward
higher values of PC1 for the EE-EGCG Ts65Dn group which
almost reaches significance (p-value = 0.08, Figure S7D). No
significance differences were detected on the first reversal session
(Figure S7C). It is likely that a greater number of sessions would
increase the difference between double treated trisomics and
untreated ones in a similar way as in the acquisition. Significant
pairwise group comparisons during reversal sessions 1 and 3
based on PC1 can be found in Supplementary Tables 3, 4,
respectively.
DISCUSSION
Individuals with DS undergo a progressive age-associated
neurodegenerative process that resembles that of AD. Early signs
of dementia in people with DS are the dysfunction of the frontal
lobe and hippocampus, where amyloid first accumulates during
the early stages. Cognitive symptoms of dementia in people with
DS are similar to those of AD patients and include forgetfulness,
impaired short-termmemory, confusion, learning problems, and
deficits in visuospatial organization (Lott and Dierssen, 2010).
Some of these symptoms are recapitulated in DS mouse models,
such as the Ts65Dn mice (Holtzman et al., 1996; Granholm et al.,
2000).
The present study was aimed to investigate the potential
of a combined treatment with EE and a green tea extract
containing EGCG to ameliorate the hippocampal-dependent
spatial learning and memory deficits in Ts65Dnmice at the age of
the onset of cognitive decline. Besides the classical single-variate
analysis, we applied here a novel multidimensional approach
for the analysis of the effects of the different genotypes and
treatments. To achieve the best discrimination between groups
we used a supervised PCA involving the group medians on
each acquisition session of a number of behavioral variables
that are differentially modified during the learning process
(see Materials and Methods). PCA has been applied to MWM
analysis before. In a study from Keeley and McDonald (2015)
a number of MWM navigation-related variables are mixed
with variables characterizing the individuals to then identify
the main contributors to overall variance as obtained by PCA.
A very comprehensive MWM-related PCA study (Wolfer and
Lipp, 2000) analyzed over 3000 mice from a large number
of individual experiments. The approach allowed identifying
a large degree of variance unrelated to spatial learning and
was used to warn about oversimplified approaches disregarding
variation caused by memory-unrelated effects. Our approach
is rather different since it works on the group level and
analyzes separately the different types of sessions. The amount
of variance unrelated to genotype or treatment is taken into
account by evaluating the within-group variance separately
(which also enables a permutation-based significance analysis).
This approach is known as discriminant analysis, and in its linear
variant (LDA) has been used to classify swim paths in the MWM
(Graziano et al., 2003). Our discriminant analysis based on PCA
allowed depicting the 5-day trajectories of each experimental
group through a space spanned by a speed-related variable
and a composite learning variable. This composite learning
variable reflects global treatment-induced learning differences.
Traditionally, PCA does not address exact hypothesis testing,
and is only used to identify which variables account for large
proportions of variance in data sets, which can then inform the
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FIGURE 5 | The first principal component of the PCA (PC1) discriminates good learners from poor learners in the Ts65Dn groups. (A) Density distribution
of all Ts65Dn groups for the first and the second principal components of the PCA (PC1 and PC2). On the first acquisition session all Ts65Dn groups showed a similar
value on PC1, which can be interpreted as a composite variable explaining learning, indicating a comparable basal performance of all Ts65Dn animals. (B) TS-EE and
TS-EE-EGCG mice manifested higher values of PC1 on the fifth acquisition session, at the end of the learning phase, explained by the benefits of the treatment on the
learning process on these groups. On this session groups were also more spread because within group individual phenotypic differences also increased during the
learning process. Boxplots of the distribution of the first principal component for each Ts65Dn group on the first (C) and the fifth (D) session of the acquisition phase.
In each boxplot, the horizontal line corresponds to group median, the box edges gives the 25th and 75th percentiles and the whiskers depict minimum and maximum
values to a maximum of 1.5 times the interquartile distance from the box. More extreme values are individually plotted. TS-EE-EGCG reached significant higher values
on the composite learning variable than TS and TS-EGCG mice on the fifth acquisition session. Permutation test *p < 0.05, **p < 0.01.
choice of statistical tests among variables for ANOVA testing.
Here, we applied a permutation test procedure that allowed
for precise statistical significance estimations both in terms of
explained variance and with respect to distances in PC1. This test
has the advantage that it does not require a post-hoc correction
for multiple comparisons or many variables. PC1 combines
similarly sized contributions from six main learning-related
variables that accounted for 74% of the between-group variance
along the five learning sessions, and all variables, except speed,
load similarly on this composite learning performance measure.
This argues that all these variables capture the same amount of
information concerning learning, and although in some aspects
they may be redundant, they are essentially measuring slightly
different learning aspects. In contrast, the second principal axis
(PC2, 12% of variance) is dominated by the contribution of
swimming speed and thus is mainly dependent on motor ability.
However, speed also contributes to PC1, and is thus decomposed
into a learning-dependent component (mice go faster to a
target they have learned) and a learning-independent component
(related with intrinsic motor capability). We also applied our
multidimensional analysis to the reversal sessions. In this case,
PC1 can also be interpreted as a composite variable explaining
learning (re-learning of a new platform location related to
cognitive flexibility).
As previously described, in our study both single-variate and
PCA analysis showed spatial learning impairment in 6–7 months
old Ts65Dn mice, as reflected along the acquisition sessions
by an increased latency to reach the platform accompanied
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by increased Gallagher index and thigmotactic behavior as
compared to WT mice. Ts65Dn performance reached a
maximum value of PC1 (composite learning measure) in the
last learning session, which corresponded to initial PC1 values
(learning sessions 1 and 2) of untreated WT, indicating a global
learning impairment in trisomic mice. In addition, Ts65Dn
mice showed an impoverished reference memory, as indicated
by the significantly increased Gallagher index in the probe
trial (removal session). Finally, cognitive flexibility impairment
was detected in the reversal sessions as revealed by increased
permanence in the previously trained quadrant, which prevented
an adequate search shift to the new location of the platform.
These results confirm previous studies showing that performance
of Ts65Dn mice in the MWM is indicative of poor learning
strategies and hippocampal-dependent learning and memory
dysfunction (reviewed by Dierssen, 2012). Such impairment is
detected from early stages and undergoes an age-related decline
due to degenerative processes in the septo-hippocampal system
(Holtzman et al., 1996; Granholm et al., 2000). Interestingly,
the density plots especially of the trisomic groups on PC1 and
PC2 revealed an increased within-group variance after learning
(Figure 5), suggesting that some trisomic individuals learned
better than others.
Consistently with previous findings (Martínez-Cué et al.,
2002; Dierssen et al., 2003; Baamonde et al., 2011; Chakrabarti
et al., 2011) we found that 1 month exposure to an enriched
environment (EE) had a moderate effect on spatial learning
impairment of 5–6 months old female trisomic mice, improving
the efficiency in learning strategies across the acquisition sessions
as shown by a reduction in the Gallagher index, in thigmotaxis
and in the latency to reach the platform. These results are
consistent with previous findings showing that EE induces
positive though limited behavioral effects in young Ts65Dn mice.
In fact, in our experiments EE had no effects on the latency
to reach the platform or on the Gallagher index in WT mice,
although it promoted a significant reduction in their percentage
of time in the periphery along acquisition days (Figure S1),
suggesting a more exploratory behavior. This is consistent with
previous work in this strain (Martínez-Cué et al., 2002) that also
reported reduced distances traveled in the periphery in young
WT females. Different factors could account for these moderate
effects of EE including gender, genetic background, or age of
initiation of EE exposure.
In our study, EGCG administered for 1 month at the age
of 5–6 months, did not improve spatial learning of neither
WT nor Ts65Dn mice, despite the promising previous results
in young Ts65Dn (De la Torre et al., 2014). Furthermore,
EGCG-treated Ts65Dn group showed a trajectory in the PCA
which had higher values of PC2 than untreated Ts65Dn
indicating a general reduction in swimming speed during
learning upon treatment. Since at 5–6 months of age Ts65Dn
mice already show some age-associated cognitive decline and
AD-like neuropathology (Granholm et al., 2000), it could be
speculated that 1 month of treatment with EGCG at the dosage
used in this study is not sufficient to reverse these effects, even
though we cannot discard that a chronic treatment, initiating
the administration of EGCG at earlier ages, or increasing the
dosage, could restore the cognitive deficits in older trisomic
animals.
Interestingly, the administration of EGCG in combination
with EE was the most efficient in improving the spatial
learning and memory impairment in Ts65Dn mice. EE-EGCG
treatment markedly reduced escape latency, Gallagher index, and
thigmotaxis. The PCA showed that EE-EGCG treated Ts65Dn
group had higher values of PC1 than the rest of Ts65Dn mice
groups, attaining maximum values of PC1 that were equal to
those reached by untreated WT at the end of the learning phase
(efficient-learning trajectory), thus suggesting a recovery of the
phenotype. Regarding the reversal learning, mainly dependent on
the prefrontal cortex functional integrity (De Bruin et al., 1994),
according to the single-variate analysis none of the treatments
were able to counteract Ts65Dn deficits. The PCA showed that
EE-EGCG treatment in Ts65Dn mice was able to induce a
marginal effect (p-value 0.08) at the 3rd session. The differences
in EE-EGCG effects during the acquisition and the reversal
sessions may be due to dysfunctions in different neural systems
affecting Ts65Dn mice, involving both the hippocampus and the
prefrontal cortex, which may not be equally ameliorated by the
treatments.
The fact that both EE and EE-EGCG promoted similar
effects, suggests that the combined administration of EE-EGCG
enhanced the beneficial effect of EE. In fact, many of the effects
reported for EE are overlapping those reported upon EGCG
treatment, such as neuroplasticity enhancement, antioxidant
activity, anti-inflammatory function, neuroprotection,
promotion of the non-amyloidogenic proteolytic pathway
of APP and modulation of the kinase activity of DYRK1A
(for a review see Xicota et al., 2015). Specifically, EE induces
a reduction of Aβ plaques (Jankowsky et al., 2005; Lazarov
et al., 2005; Berardi et al., 2007; Li et al., 2013; Polito et al.,
2014), of oxidative stress (Mármol et al., 2015) and increase in
neurotrophins such as NGF and BDNF at the basal forebrain
and other brain regions affected both in AD and DS (Ickes
et al., 2000; Birch et al., 2013). Additionally, in young Ts65Dn
mice short- and long-term exposure to EE has shown to
reduce inhibitory neurotransmission (Begenisic et al., 2011)
and rescue hippocampal cell proliferation and neurogenesis
within the dentate gyrus (Chakrabarti et al., 2011). A recent
paper by Gundimeda et al. (2014) shed light on other possible
mechanisms as they showed that EGCG was able to potentiate
the neuritogenic ability of BDNF in PC12 cells which ectopically
expressed TrkB, the BDNF high affinity receptor, through the
interaction with its high-affinity target 67-kDa laminin receptor
(67LR), a non-integrin type cell-surface associated protein that is
present in various regions of the brain. Thus, we could speculate
that EGCG may enhance the beneficial effect of EE due to
synergistic cellular and molecular effects between EE and EGCG
since they share common functions.
High within-group variance as illustrated in density plots
showed that some individuals learned better than others. In
Ts65Dn mice all the treatments increased variability, indicating
that some individuals are more sensitive than others to the effects
of EE and the combined EE-EGCG treatment. On the other
hand, a quantitative evaluation of individual variance revealed
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statistically significant differences of the composite learning
variable between the EE-EGCG treated Ts65Dn compared with
their untreated or EGCG-treated counterparts at the end of the
learning process. This indicates that EE-EGCG treatment is able
to globally modify the learning related behavior.
In conclusion, we demonstrated here that combined treatment
of EGCG and EE had beneficial effects on age-related cognitive
impairment in Ts65Dn mice. We speculate that this may
be due to synergistic cellular and molecular effects between
EE and EGCG since they share common functions such
as neuroplasticity enhancement, antioxidant activity, anti-
inflammatory function, neuroprotection, promotion of the non-
amyloidogenic proteolytic pathway of APP, and Dyrk1A kinase
activity inhibition. PCA highlighted the way in which variables
contributed to the variance in our data sets. As discussed above,
it identified a composite learning variable and demonstrated an
increased variance along the learning process within all groups
and identified some trisomic individuals as more prone to the
effects of EE and the combined EE-EGCG treatment than others.
Overall results suggest that the combination of EGCG and EE
could be an efficient therapeutic strategy in older DS individuals
although there may be a large heterogeneity in the clinical
outcome (responders and non-responders).
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